Sigma Investment Counselors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14M | Buy |
9,299
+548
| +6% | +$244K | 0.23% | 71 |
|
|
2025
Q1 | $4.24M | Sell |
8,751
-251
| -3% | -$122K | 0.26% | 62 |
|
|
2024
Q4 | $3.63M | Buy |
9,002
+65
| +0.7% | +$26.2K | 0.21% | 71 |
|
|
2024
Q3 | $4.16M | Buy |
8,937
+260
| +3% | +$121K | 0.24% | 67 |
|
|
2024
Q2 | $4.07M | Buy |
8,677
+515
| +6% | +$241K | 0.25% | 68 |
|
|
2024
Q1 | $3.41M | Buy |
8,162
+910
| +13% | +$380K | 0.22% | 72 |
|
|
2023
Q4 | $2.95M | Buy |
7,252
+5,909
| +440% | +$2.4M | 0.21% | 70 |
|
|
2023
Q3 | $467K | Buy |
1,343
+74
| +6% | +$25.7K | 0.04% | 130 |
|
|
2023
Q2 | $447K | Hold |
1,269
| – | – | 0.03% | 132 |
|
|
2023
Q1 | $400K | Hold |
1,269
| – | – | 0.03% | 139 |
|
|
2022
Q4 | $366K | Sell |
1,269
-13
| -1% | -$3.75K | 0.03% | 141 |
|
|
2022
Q3 | $371K | Sell |
1,282
-9
| -0.7% | -$2.61K | 0.03% | 134 |
|
|
2022
Q2 | $364K | Hold |
1,291
| – | – | 0.03% | 137 |
|
|
2022
Q1 | $337K | Sell |
1,291
-826
| -39% | -$216K | 0.02% | 147 |
|
|
2021
Q4 | $465K | Buy |
2,117
+127
| +6% | +$27.9K | 0.03% | 135 |
|
|
2021
Q3 | $361K | Buy |
1,990
+148
| +8% | +$26.8K | 0.03% | 141 |
|
|
2021
Q2 | $371K | Buy |
1,842
+27
| +1% | +$5.44K | 0.03% | 139 |
|
|
2021
Q1 | $390K | Buy |
1,815
+266
| +17% | +$57.2K | 0.03% | 134 |
|
|
2020
Q4 | $366K | Buy |
+1,549
| New | +$366K | 0.03% | 135 |
|
|
2020
Q3 | – | Sell |
-980
| Closed | -$285K | – | 154 |
|
|
2020
Q2 | $285K | Buy |
+980
| New | +$285K | 0.03% | 129 |
|
|
2019
Q3 | – | Sell |
-1,177
| Closed | -$216K | – | 162 |
|
|
2019
Q2 | $216K | Buy |
1,177
+22
| +2% | +$4.04K | 0.03% | 150 |
|
|
2019
Q1 | $212K | Buy |
+1,155
| New | +$212K | 0.03% | 148 |
|
|
2018
Q4 | – | Sell |
-1,169
| Closed | -$225K | – | 154 |
|
|
2018
Q3 | $225K | Buy |
+1,169
| New | +$225K | 0.03% | 139 |
|